Product
Transthyretin (ATTR) Amyloidosis
1 clinical trial
6 indications
Indication
Transthyretin AmyloidosisIndication
amyloid cardiomyopathyIndication
ATTRv-PNIndication
ATTR mixedIndication
hATTRClinical trial
A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients With Transthyretin (ATTR) AmyloidosisStatus: Not yet recruiting, Estimated PCD: 2031-06-27